Examinando por Autor "Risco-Risco, Carlos"
Mostrando 1 - 1 de 1
- Resultados por página
- Opciones de ordenación
Ítem Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis(MDPI, 2024-11-05) Risco-Risco, Carlos; Henriquez-Camacho, César; Herrera-Rueda, Marta; Barberán, José; Andaluz-Ojeda, DavidThis study aims to assess the effectiveness and safety of cefiderocol in treating severe infections caused by multidrug-resistant Gram-negative bacteria (MDR-GNB) in critically ill patients, particularly those in intensive care units (ICUs).